Back | Next |
home / stock / syrs / syrs message board
Subject | By | Source | When |
---|---|---|---|
and the shorts continue | hedge_fun | investorshub | 04/04/2023 3:09:27 AM |
Price trading up | INFINITI | investorshub | 04/03/2023 9:57:03 PM |
$SYRS MomentumIts gaining | hedge_fun | investorshub | 04/02/2023 6:34:45 PM |
Brookline Capital Markets remains a Buy on $SYRS | splintered sunlight | investorshub | 11/14/2022 9:43:55 PM |
Then lets hope for 2... | splintered sunlight | investorshub | 10/03/2022 4:53:34 PM |
TD Ameritrade has $SYRS Short % of float | OCEANIC 815 | investorshub | 09/30/2022 2:26:21 PM |
Dont see it happening | INFINITI | investorshub | 09/16/2022 8:10:01 PM |
$SYRS come dollar a/h ? weee | knrorrel | investorshub | 09/16/2022 8:08:44 PM |
Lets break that dollar and open @ $50 | INFINITI | investorshub | 09/13/2022 11:04:21 PM |
This one is bound to pop to 1+ | PennyPusher786 | investorshub | 09/13/2022 10:23:11 PM |
Awesome NEWS!!!! | INFINITI | investorshub | 09/13/2022 8:11:10 PM |
Syros Receives FDA Orphan Drug Designation for SY-5609 | INFINITI | investorshub | 09/13/2022 8:10:58 PM |
Thanks | Expensivetaste281 | investorshub | 09/12/2022 11:48:01 PM |
Lol.... They wanna load the boat before it | PennyPusher786 | investorshub | 09/12/2022 11:40:30 PM |
Why | Expensivetaste281 | investorshub | 09/12/2022 11:39:38 PM |
Dark Pool Trades dumping on the run | PennyPusher786 | investorshub | 09/12/2022 10:22:38 PM |
Wooooohooo, got in just in time, 15 minutes | PennyPusher786 | investorshub | 09/12/2022 10:07:27 PM |
My advice is sell as soon as possible. | cardvic | investorshub | 08/17/2022 8:11:18 AM |
On the Merger with$ TYME Pharma coming soon. | mcsharkey | investorshub | 08/01/2022 8:12:55 PM |
Hopefully $5!!! | splintered sunlight | investorshub | 07/14/2022 1:17:25 PM |
News, Short Squeeze, Breakout and More Instantly...
Syros Pharmaceuticals Inc. Company Name:
SYRS Stock Symbol:
NASDAQ Market:
2024-06-18 10:10:00 ET June 18, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform covering biotech and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring A...
-- Three medical experts will join members of Syros’ leadership team to provide an overview of HR-MDS patient management, perspectives on the current and future treatment landscape, and the opportunity for tamibarotene on Tuesday, June 25 at 11:00 a.m. ET -- -- Syros expects to rep...
2024-05-27 04:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...